Xiang Wu

发表

In Vitro ADME Profiling Using High-Throughput RapidFire Mass Spectrometry

Lory R Tan, Xiang Wu, Jing Wang, 2012, Journal of biomolecular screening.

Further Comparison of Primary Hit Identification by Different Assay Technologies and Effects of Assay Measurement Variability

Ji-Hu Zhang, Xiang Wu, Xiang Wu, 2005, Journal of biomolecular screening.

Comparison of Assay Technologies for a Tyrosine Kinase Assay Generates Different Results in High Throughput Screening

Robert Schweitzer, Jinzi J Wu, Xiang Wu, 2002, Journal of biomolecular screening.

Identification and Characterization of Small-Molecule Inhibitors of the R132H/R132H Mutant Isocitrate Dehydrogenase 1 Homodimer and R132H/Wild-Type Heterodimer

Xiang Wu, Jing Wang, Wentao Zhang, 2014, Journal of biomolecular screening.

Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors.

Charles R. Holst, J. Nuss, Xiang Wu, 2012, Journal of medicinal chemistry.

The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors.

Wei Xu, Wei Cheng, F. Yakes, 2012, Bioorganic & medicinal chemistry letters.

Comparison of Assay Technologies for a Nuclear Receptor Assay Screen Reveals Differences in the Sets of Identified Functional Antagonists

J Fraser Glickman, B. Bowen, Xiang Wu, 2003, Journal of biomolecular screening.

Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonists.

Aaron Shipway, L. Mattheakis, J. Nuss, 2012, Journal of medicinal chemistry.

A Comparison of ALPHAScreen, TR-FRET, and TRF as Assay Methods for FXR Nuclear Receptors

J Fraser Glickman, B. Bowen, Xiang Wu, 2002, Journal of biomolecular screening.